Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations?

6 Jul 2022

Abstract excerpt

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Research and Pathophysiology
Share to Lysosomal Storage Disorders Research
Share to Sphingolipid Metabolism and Signaling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35792565
DOI: 10.1002/mds.29132

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations?PMID 35792565Read ↗

Association between plasma glucosylsphingosine levels and dyskinesia burden in GBA1-related Parkinson's disease.Semantic proximity Read ↗

Glucocerebrosidase dysfunction in GBA1 carriers: insights from blood and macrophage analyses.Semantic proximity Read ↗

Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson's disease.Semantic proximity Read ↗

Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease.Semantic proximity Read ↗

Plasma Glucosylsphingosine in GBA1 E365K, N409S, and L483P Heterozygous Mutation Carriers.Semantic proximity Read ↗

Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease.Semantic proximity Read ↗

Gaucher Disease Diagnosis Using Lyso-Gb1 on Dry Blood Spot Samples: Time to Change the Paradigm?Semantic proximity Read ↗

Metabolomic Changes in Idiopathic and <i>GBA1</i> Parkinson’s DiseaseSemantic proximity Read ↗

Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment Decisions in Patients with Gaucher Disease.Semantic proximity Read ↗

CSF glucosylsphingosine is a central readout of GCase impairment across genetic and sporadic Parkinson’s diseaseSemantic proximity Read ↗

CSF Sphingolipids in Parkinson Disease and Dementia with Lewy Bodies with and without GBA1 variantsSemantic proximity Read ↗

A Biomarker Study in Patients with GBA1-Parkinson's Disease and Healthy Controls.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.